REFERENCES
1. Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int 2019;39 Suppl 1:19-31.
3. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004;40:472-7.
4. Buettner S, van Vugt JL, IJzermans JN, Groot Koerkamp B. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther 2017;10:1131-42.
5. Spolverato G, Vitale A, Cucchetti A, et al. Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? Cancer 2015;121:3998-4006.
6. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014;60:1268-89.
7. Primrose JN, Fox RP, Palmer DH, et al. BILCAP study group. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 2019;20:663-73.
8. Morise Z, Aldrighetti L, Belli G, et al. ILLS-Tokyo Collaborator group. Laparoscopic repeat liver resection for hepatocellular carcinoma: a multicentre propensity score-based study. Br J Surg 2020;107:889-95.
9. Morise Z, Ciria R, Cherqui D, Chen KH, Belli G, Wakabayashi G. Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease. J Hepatobiliary Pancreat Sci 2015;22:342-52.
10. Fretland ÅA, Dagenborg VJ, Waaler Bjørnelv GM, et al. Quality of life from a randomized trial of laparoscopic or open liver resection for colorectal liver metastases. Br J Surg 2019;106:1372-80.
11. Fretland ÅA, Kazaryan AM, Edwin B. Laparoscopic resection for liver malignancies: do the elderly benefit more? J Invest Surg 2019;32:83-4.
12. Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg 2009;250:831-41.
13. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008;248:84-96.
14. Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 2013;153:811-8.
15. Ribero D, Pinna AD, Guglielmi A, et al. Italian Intrahepatic Cholangiocarcinoma Study Group. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg 2012;147:1107-13.
16. Spolverato G, Kim Y, Alexandrescu S, et al. Is hepatic resection for large or multifocal intrahepatic cholangiocarcinoma justified? Results from a multi-institutional collaboration. Ann Surg Oncol 2015;22:2218-25.
17. Abbas S, Sandroussi C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB 2013;15:492-503.
18. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007;245:755-62.
19. van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 2013;36:25-34.
20. Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery 2002;132:555-63; discission 563.
21. Weber SM, Ribero D, O'Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB 2015;17:669-80.
22. Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM. Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer 2013;119:3929-42.
23. Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 2010;17:1324-9.
24. Bagante F, Spolverato G, Weiss M, et al. Assessment of the lymph node status in patients undergoing liver resection for intrahepatic cholangiocarcinoma: the new eighth edition AJCC staging system. J Gastrointest Surg 2018;22:52-9.
25. Spolverato G, Bagante F, Weiss M, et al. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma. J Surg Oncol 2017;115:696-703.
26. Regmi P, Hu HJ, Paudyal P, et al. Is laparoscopic liver resection safe for intrahepatic cholangiocarcinoma? A meta-analysis. Eur J Surg Oncol 2021;47:979-89.
27. Wang J, Ma D, Du G, et al. Laparoscopic vs. open anatomical hepatectomy for intrahepatic cholangiocarcinoma: a retrospective cohort study. Front Surg 2022;9:1003948.
28. Sahakyan MA, Aghayan DL, Edwin B, et al. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: a multicenter propensity score-matched study. Scand J Gastroenterol 2023;58:489-96.
29. Vitale A, Moustafa M, Spolverato G, Gani F, Cillo U, Pawlik TM. Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2016;113:685-91.
30. Yoh T, Cauchy F, Le Roy B, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study. Surgery 2019;166:975-82.
31. Li F, Jiang Y, Jiang L, et al. Effect of lymph node resection on prognosis of resectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Front Oncol 2022;12:957792.
32. Sposito C, Droz Dit Busset M, Virdis M, et al. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: a review. Eur J Surg Oncol 2022;48:150-9.
33. Kim SH, Han DH, Choi GH, Choi JS, Kim KS. Extent of Lymph Node Dissection for Accurate Staging in Intrahepatic Cholangiocarcinoma. J Gastrointest Surg 2022;26:70-6.
34. Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg 2013;17:1917-28.
35. Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer 2018;124:74-83.
36. Kim BJ, Newhook TE, Tzeng CD, et al. Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol 2022;126:658-66.
37. Kang SH, Choi Y, Lee W, et al. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching. Surg Oncol 2020;33:63-9.
38. Hobeika C, Cauchy F, Fuks D, et al. AFC-LLR-2018 study group. Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis. Br J Surg 2021;108:419-26.
39. Lee SJ, Kang SH, Choi Y, et al. Long-term outcomes of laparoscopic versus open liver resection for intrahepatic combined hepatocellular-cholangiocarcinoma with propensity score matching. Ann Gastroenterol Surg 2022;6:562-8.
40. Martin SP, Drake J, Wach MM, et al. Laparoscopic approach to intrahepatic cholangiocarcinoma is associated with an exacerbation of inadequate nodal staging. Ann Surg Oncol 2019;26:1851-7.
41. Ratti F, Cipriani F, Ariotti R, et al. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution. Surg Endosc 2016;30:1999-2010.
42. Ratti F, Casadei-Gardini A, Cipriani F, et al. Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes. J Clin Med 2021;10:2828.
44. Mejia A, Cheng SS, Vivian E, Shah J, Oduor H, Archarya P. Minimally invasive liver resection in the era of robotics: analysis of 214 cases. Surg Endosc 2020;34:339-48.
45. Bozkurt E, Sijberden JP, Hilal MA. What is the current role and what are the prospects of the robotic approach in liver surgery? Cancers 2022;14:4268.
46. Kamarajah SK, Bundred J, Manas D, Jiao L, Hilal MA, White SA. Robotic versus conventional laparoscopic liver resections: A systematic review and meta-analysis. Scand J Surg 2021;110:290-300.
47. Rahimli M, Perrakis A, Andric M, et al. Does robotic liver surgery enhance R0 results in liver malignancies during minimally invasive liver surgery?-A systematic review and meta-analysis. Cancers 2022;14:3360.
48. Hamad A, Ansari A, Li Y, et al. Short- and long-term outcomes following robotic and open resection for intrahepatic cholangiocarcinoma: a national cohort study. Surg Oncol 2022;43:101790.
49. Piccolo G, Barabino M, Lecchi F, et al. Laparoscopic indocyanine green fluorescence imaging for intrahepatic cholangiocarcinoma. Am Surg 2022:31348221103659.
50. Franz M, Arend J, Wolff S, et al. Tumor visualization and fluorescence angiography with indocyanine green (ICG) in laparoscopic and robotic hepatobiliary surgery - valuation of early adopters from Germany. Innov Surg Sci 2021;6:59-66.
51. Marino MV, Podda M, Fernandez CC, Ruiz MG, Fleitas MG. The application of indocyanine green-fluorescence imaging during robotic-assisted liver resection for malignant tumors: a single-arm feasibility cohort study. HPB 2020;22:422-31.
52. Uy BJ, Han HS, Yoon YS, Cho JY. Laparoscopic liver resection for intrahepatic cholangiocarcinoma. J Laparoendosc Adv Surg Tech A 2015;25:272-7.
53. Lee W, Park JH, Kim JY, et al. Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Surg Endosc 2016;30:4835-40.
54. Wei F, Lu C, Cai L, Yu H, Liang X, Cai X. Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas? Surg Endosc 2017;31:3646-55.
55. Zhu Y, Song J, Xu X, Tan Y, Yang J. Safety and feasibility of laparoscopic liver resection for patients with large or multiple intrahepatic cholangiocarcinomas: A propensity score based case-matched analysis from a single institute. Medicine 2019;98:e18307.
56. Kinoshita M, Kanazawa A, Takemura S, et al. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma. Asian J Endosc Surg 2020;13:46-58.
57. Wu J, Han J, Zhang Y, et al. Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma. Biosci Trends 2020;14:376-83.
58. Haber PK, Wabitsch S, Kästner A, et al. Laparoscopic liver resection for intrahepatic cholangiocarcinoma: a single-center experience. J Laparoendosc Adv Surg Tech A 2020;30:1354-9.
59. Brustia R, Laurent A, Goumard C, et al. AFC-ICC-2009; AFC-LLR-2018; PRS-2019 Study group. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: report of an international multicenter cohort study with propensity score matching. Surgery 2022;171:1290-302.
60. Shapera EA, Ross S, Syblis C, Crespo K, Rosemurgy A, Sucandy I. Analysis of oncological outcomes after robotic liver resection for intrahepatic cholangiocarcinoma. Am Surg 2022:31348221093933.
